Literature DB >> 1660401

Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism. I. Medullary thyroid carcinoma animal model.

K Horiuchi1, I Yomoda, H Ohta, K Endo, A Yokoyama.   

Abstract

To search for the tumour localization mechanism of Tc(V)-DMS, a polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS], the development of medullary thyroid carcinoma (MTC) bearing mouse model was considered. Subcutaneously transplanted tumour was allowed to grow for 2, 4 and 6 weeks, and the influence of the tumour stage on the biodistribution of Tc(V)-DMS was screened. High radioactivity uptake in the tumour tissue was observed, and this accumulation showed a direct correlation with tumour growth and calcitonin secretion, the MTC marker detectable in the blood serum. The gathered data implicated some calcitonin-related factors as the mediator in the Tc(V)-DMS localization; participation of a phosphate-like oxoanion, TcO4(3-), is strongly suggested not only by the high radioactivity accumulation in the calcitonin-producing tumour but also by the accumulation in the bones of this model animal.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660401     DOI: 10.1007/bf00175057

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.

Authors:  S E Clarke; C Lazarus; R Mistry; M N Maisey
Journal:  Br J Radiol       Date:  1987-11       Impact factor: 3.039

2.  [Tumor imaging using Tc(V)-99m dimercaptosuccinic acid, a newly developed radiopharmaceutical: its clinical usefulness].

Authors:  H Ohta; K Endo; M Koizumi; T Fujita; H Sakahara; T Nakashima; K Torizuka; N Hata; H Masuda; I Yomoda
Journal:  Kaku Igaku       Date:  1985-11

3.  99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.

Authors:  A Miyauchi; K Endo; H Ohta; K Torizuka; F Matsuzuka; A Kobayashi; K Kuma; M Maeda
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

4.  Transplantable calcitonin-secreting medullary carcinomas of the thyroid in the WAG-Rij rat.

Authors:  G A Boorman; J N Heersche; C F Hollander
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

5.  On medullary carcinoma of the thyroid.

Authors:  O Ljungberg
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1972

Review 6.  Calcitonin and phosphate.

Authors:  R V Talmage; C J VanderWiel; J L Matthews
Journal:  Mol Cell Endocrinol       Date:  1981-12       Impact factor: 4.102

7.  The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent.

Authors:  A Yokoyama; N Hata; K Horiuchi; H Masuda; H Saji; H Ohta; K Yamamoto; K Endo; K Torizuka
Journal:  Int J Nucl Med Biol       Date:  1985

8.  A new imaging agent for medullary carcinoma of the thyroid.

Authors:  H Ohta; K Yamamoto; K Endo; T Mori; D Hamanaka; A Shimazu; K Ikekubo; K Makimoto; Y Iida; J Konishi
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

9.  Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.

Authors:  M C Patel; R B Patel; P Ramanathan; N Ramamoorthy; B A Krishna; S M Sharma
Journal:  Eur J Nucl Med       Date:  1988

10.  Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidine.

Authors:  D Guilloteau; J L Baulieu; J C Besnard
Journal:  Eur J Nucl Med       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.